| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |